French pharma major Sanofi (Euronext: SAN) has met analyst estimates for its fourth-quarter 2024 profit and confirmed plans for a 5 billion euro ($5.5 billion) share buyback program in 2025. The ...

The value of time depends on your unique personal and business goals, your industry, the availability of technology and ...

P.E.I.'s chief public health officer says the province has decided to pause the establishment of a supervised injection site ...

Senators grilled Robert F. Kennedy Jr. on vaccines, abortion and Medicaid in his confirmation hearing to lead HHS. RFK Jr.

ROSELAND, N.J. - Milestone Scientific Inc. (NYSE: NYSE:MLSS), a developer of advanced drug delivery instruments with a market ...

Nevada’s shortage of doctors stems from a lack of residencies, three to five-year training programs that are required for ...

Nicole Grajewski is a Fellow in the Nuclear Policy Program at the Carnegie Endowment for International Peace and an Associate ...

Trump unveils ambitious $500 billion 'Project Stargate' AI initiative with tech giants OpenAI, Oracle, and SoftBank, sparking controversy as Elon Musk questions funding and environmentalists raise ...

Trustmark Corporation ( NASDAQ: TRMK) Q4 2024 Earnings Conference Call January 29, 2025 8:30 AM ET Joey Rein - Director of Corporate Strategy Duane Dewey - President & Chief Executive Officer Barry ...

This is Dermata's first issued U.S. patent for XYNGARI™, which uses its Spongilla technology to topically treat acne - - Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI™ ...

Welcome to the Q4 2024 Intuitive earnings conference call. At this time, all participants are in a listen-only mode. Please ...

“On behalf of Vaxart and its Board, I would like to thank Bob for his years of service and contributions to our Company,” said Vaxart Board Chairman, Dr. Michael J. Finney.